Anesthesia and Respiratory Care Products and Technologies

  • MIRUS ...explore the difference

Anesthesia and respiratory filtration products provide patients, staff, and equipment with an efficient barrier to contamination while reducing costs.

Heat and Moisture Exchange Filters

Nosocomial pneumonia is the third most common hospital-acquired infection in an intensive care environment. In mechanically ventilated patients, the incidence of nosocomial pneumonia ranges from 9 to 68%, and mortality rates range from 33 to 71%.

Heat and moisture exchanging filters can be an effective hygienic measure for protection against nosocomial infections; however, not all HME Filters are the same. Pleated, hydrophobic membrane HME Filters prevent liquid from passing into the ventilator circuit and effectively isolate the patient from microbiological contaminants.

Ultimately, the use of an appropriate HME Filter can realize significant cost savings and a reduction in overall Ventilator Associated Pneumonia (VAP) rates.

Multiple-Patient-Use Anesthesia Circuits

A single Pall Ultipor™ Anesthesia Breathing Circuit System can be used for all procedures performed within a 24-hour period, as long as each new patient is provided with a fresh Pall patient kit. The advantages of using the same circuit for multiple patients are clear:
  • Fewer circuits are used, saving money
  • Less medical waste is generated, decreasing disposal costs
  • Operating room turnover time is decreased, saving staff effort
  • Patients and staff are protected from machine contamination
  • Machines are protected from patient contamination

Pulmonary Function Testing

The Pall Pro-Tec PF30S Filter is indicated for use with pulmonary function test equipment to retain saliva, microdroplets, and secretion present in patient's expiratory gas. The Pall PF30S filters help to decrease contamination of equipment, which may lead to subsequent alterations in pulmonary function test results. The Pall PF30S also reduces the risk of patient cross-contamination.

Clinical studies have shown that the Pall PF30S has no clinically significant effect on most static and dynamic pulmonary function test results, like VC, FVC, FEF1, FEF25-75%,  FEF50%, PEFR, RV, FRC, TLC, TLCO, KCO, VA.1,2,3 


1. Strauss R et al. Pneumologie. 1993;47:626-30

2. Rust M. Atems-und Lungenkrankheiten. 1989:211

3. Miralda R. XVII dia de pneumológia. 1999


MIRUS™ System
MIRUS™ System
This product is not cleared by US FDA for sale within the USA.
New Hospital Catalog
New Hospital Catalogue
View our selection of hospital products for Europe.
Product documents, training and more.
Find Pall Medical conferences, webinars and links to industry information.